Skip to main content

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users.

Click Here To Get Detailed Description of Chatbots in Healthcare Market

The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well.



The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers.

New start-ups are coming up with different chatbot application offerings. Consequently, no company has a majority of share in the market. For instance, while Babylon Health provides symptom assessment and health checker chatbot services in English, Intermedia’s Symptomate provides its symptom assessor in 10 different languages.
Different application areas for chatbots include mental health (Woebot Labs Inc, X2), medication reminder (to improve medication adherence) and post discharge instruction adherence to reduce the incidence of readmissions in the hospitals. Examples of chatbots ensuring adherence to medicines and to the instructions are Florence, NorthWell Chats. The upcoming applications include its usage in life sciences and pharmaceutical industry (Lupin’s Anya).

Though the industry has a significant number of start-ups, it has also gained attention of big players such as Microsoft Corporation, Google LLC, and Amazon.com, Inc. While these giant players have shown interest in the industry; they are yet to launch any product. Currently, they are entering the market either as platform providers or as investors of different start-ups. For instance, Google LLC, instead of launching its own chatbot in the market, has developed its funding program called Google Assistant Investment Program Fund. In September 2018, the company funded a start-up Aiva Health. The start-up was also funded by Amazon.com, Inc to develop a voice assistant that can guide elderly people to connect with their care givers by using Google Home or Alexa. A significant reason for this trend is that as investors, these companies hold a certain share in the start-up, and once the latter are successful, they could be merged in the company.

The usage of chatbots have been steadily increasing with technological advancements and new entrants. The other major factors leading to the increase in use of chatbots are increased use of smart devices and better internet connectivity and need for the optimization of the healthcare system. However, there are few challenges which act as hindrance to the growth of the global chatbots in the healthcare market.

Labels:

Comments

Post a Comment

Popular posts from this blog

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...
1 comment
Read more

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...
1 comment
Read more